Hematological Malignancies Treatment Breakthrough Developed By This Major Biotech Company

Hematological Malignancies Treatment Breakthrough Developed By This Major Biotech Company.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In the rapidly evolving field of medical science, breakthroughs often come from unexpected quarters. One such development has been announced by Phio Pharmaceuticals Corp. (NASDAQ: PHIO). The biotechnology comp…